FDA Approved: EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Laurus Labs Limited)

View source ↗

Summary

FDA approves a generic fixed-dose combination of emtricitabine, rilpivirine, and tenofovir disoproxil fumarate from Laurus Labs Limited (ANDA 220232).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine, rilpivirine and tenofovir disoproxil fumarate (emtricitabine, rilpivirine, tenofovir disoproxil fumarate)

Snippet

ORIG AP for EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE)